Video

Lonza Advanced Synthesis Capabilities Update June 2026: ADC

Source: Lonza

Criostóir Ó Ciardha, Lonza’s Director of Commercial Development for Bioconjugates, will highlight Lonza’s late phase integrated bioconjugates offering at mid and large scale. He will also discuss how Lonza is addressing the challenges of emerging bioconjugate modalities as they move into larger scale manufacturing.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Lonza